Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Long-term changes in retinal vascular diameter and cognitive impairment in type 1 diabetes.

Nunley KA, Metti AL, Klein R, Klein BE, Saxton JA, Orchard TJ, Costacou T, Aizenstein HJ, Rosano C.

Diab Vasc Dis Res. 2018 May;15(3):223-232. doi: 10.1177/1479164118758581. Epub 2018 Feb 28.

PMID:
29488397
2.

Response to Comment on Nunley et al. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care 2015;38:1768-1776.

Nunley KA, Ryan CM, Saxton JA, Costacou T, Orchard TJ, Rosano C.

Diabetes Care. 2016 Feb;39(2):e25. doi: 10.2337/dci15-0028. No abstract available.

3.

Genetic Risk Score Predicts Late-Life Cognitive Impairment.

Wollam ME, Weinstein AM, Saxton JA, Morrow L, Snitz B, Fowler NR, Suever Erickson BL, Roecklein KA, Erickson KI.

J Aging Res. 2015;2015:267062. doi: 10.1155/2015/267062. Epub 2015 Aug 23.

4.

Age of Childhood Onset in Type 1 Diabetes and Functional Brain Connectivity in Midlife.

Ryan JP, Aizenstein HJ, Orchard TJ, Ryan CM, Saxton JA, Fine DF, Nunley KA, Rosano C.

Psychosom Med. 2015 Jul-Aug;77(6):622-30. doi: 10.1097/PSY.0000000000000206. Erratum in: Psychosom Med. 2016 Sep;78(7):886.

5.

Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes.

Nunley KA, Rosano C, Ryan CM, Jennings JR, Aizenstein HJ, Zgibor JC, Costacou T, Boudreau RM, Miller R, Orchard TJ, Saxton JA.

Diabetes Care. 2015 Sep;38(9):1768-76. doi: 10.2337/dc15-0041. Epub 2015 Jul 7.

6.

Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities.

Nebes RD, Snitz BE, Cohen AD, Aizenstein HJ, Saxton JA, Halligan EM, Mathis CA, Price JC, Kamboh MI, Weissfeld LA, Klunk WE.

Neuropsychologia. 2013 Sep;51(11):2202-9. doi: 10.1016/j.neuropsychologia.2013.07.017. Epub 2013 Aug 1.

7.

In vivo assessment of amyloid-β deposition in nondemented very elderly subjects.

Mathis CA, Kuller LH, Klunk WE, Snitz BE, Price JC, Weissfeld LA, Rosario BL, Lopresti BJ, Saxton JA, Aizenstein HJ, McDade EM, Kamboh MI, DeKosky ST, Lopez OL.

Ann Neurol. 2013 Jun;73(6):751-61. doi: 10.1002/ana.23797. Epub 2013 Apr 17.

8.

Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.

Cohen AD, Mowrey W, Weissfeld LA, Aizenstein HJ, McDade E, Mountz JM, Nebes RD, Saxton JA, Snitz B, Dekosky S, Williamson J, Lopez OL, Price JC, Mathis CA, Klunk WE.

Neuroimage. 2013 May 1;71:207-15. doi: 10.1016/j.neuroimage.2013.01.015. Epub 2013 Jan 24.

9.

Association between Cognitive Decline in Older Adults and Use of Primary Care Physician Services in Pennsylvania.

Fowler NR, Morrow LA, Tu LC, Landsittel DP, Snitz BE, Rodriquez EG, Saxton JA.

J Prim Care Community Health. 2012 Jul 1;3(3):201-9. doi: 10.1177/2150131911434204. Epub 2012 Feb 11.

10.

The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.

Nebes RD, Pollock BG, Perera S, Halligan EM, Saxton JA.

Am J Geriatr Pharmacother. 2012 Jun;10(3):185-92. doi: 10.1016/j.amjopharm.2012.03.003. Epub 2012 Apr 24.

11.

Amyloid imaging in dementias with atypical presentation.

Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, DeKosky ST.

Alzheimers Dement. 2012 Sep;8(5):389-98. doi: 10.1016/j.jalz.2011.07.003. Epub 2012 Jan 30.

12.

Outcomes of mild cognitive impairment by definition: a population study.

Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, Vander Bilt J, Hughes TF, Loewenstein DA, Unverzagt FW, Petersen RC.

Arch Neurol. 2011 Jun;68(6):761-7. doi: 10.1001/archneurol.2011.101.

13.

Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.

Nebes RD, Pollock BG, Halligan EM, Houck P, Saxton JA.

Am J Geriatr Psychiatry. 2011 Feb;19(2):169-75. doi: 10.1097/JGP.0b013e3181e4490d.

14.

Temporal stability of receptiveness to clinical research on Alzheimer disease.

Lingler JH, Rubin D, Saxton JA.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24 Suppl:S30-4. doi: 10.1097/WAD.0b013e3181f14ac0.

15.

Cognitive test performance predicts change in functional status at the population level: the MYHAT Project.

Ganguli M, Bilt JV, Lee CW, Snitz BE, Chang CC, Loewenstein DA, Saxton JA.

J Int Neuropsychol Soc. 2010 Sep;16(5):761-70. doi: 10.1017/S1355617710000561. Epub 2010 Jul 8.

16.

Prevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project.

Ganguli M, Chang CC, Snitz BE, Saxton JA, Vanderbilt J, Lee CW.

Am J Geriatr Psychiatry. 2010 Aug;18(8):674-83. doi: 10.1097/JGP.0b013e3181cdee4f.

17.

Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team.

Ganguli M, Snitz BE, Lee CW, Vanderbilt J, Saxton JA, Chang CC.

Aging Ment Health. 2010 Jan;14(1):100-7. doi: 10.1080/13607860903071014.

18.

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, Nebes RD, Saxton JA, Snitz BE, Aizenstein HA, Wolk DA, Dekosky ST, Mathis CA, Klunk WE.

J Neurosci. 2009 Nov 25;29(47):14770-8. doi: 10.1523/JNEUROSCI.3669-09.2009.

19.

High medical co-morbidity and family history of dementia is associated with lower cognitive function in older patients.

Morrow LA, Snitz BE, Rodriquez EG, Huber KA, Saxton JA.

Fam Pract. 2009 Oct;26(5):339-43. doi: 10.1093/fampra/cmp047. Epub 2009 Jul 7.

20.

A brief instrument to assess treatment response in the patient with advanced Alzheimer disease.

Schmitt FA, Saxton JA, Xu Y, McRae T, Sun Y, Richardson S, Li H.

Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):377-83. doi: 10.1097/WAD.0b013e3181ac9cc1.

PMID:
19571727
21.

Amyloid imaging in mild cognitive impairment subtypes.

Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, De-Kosky ST.

Ann Neurol. 2009 May;65(5):557-68. doi: 10.1002/ana.21598. Erratum in: Ann Neurol. 2009 Jul;66(1):123. DeKoskym, Steven T [corrected to De-Kosky, Steven T].

22.

Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey.

Stoehr GP, Lu SY, Lavery L, Bilt JV, Saxton JA, Chang CC, Ganguli M.

Am J Geriatr Pharmacother. 2008 Dec;6(5):255-63. doi: 10.1016/j.amjopharm.2008.11.001.

23.

Ginkgo biloba for prevention of dementia: a randomized controlled trial.

DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD; Ginkgo Evaluation of Memory (GEM) Study Investigators.

JAMA. 2008 Nov 19;300(19):2253-62. doi: 10.1001/jama.2008.683. Erratum in: JAMA. 2008 Dec 17;300(23):2730.

24.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE.

Arch Neurol. 2008 Nov;65(11):1509-17. doi: 10.1001/archneur.65.11.1509.

25.

Subjective memory complaints and concurrent memory performance in older patients of primary care providers.

Snitz BE, Morrow LA, Rodriguez EG, Huber KA, Saxton JA.

J Int Neuropsychol Soc. 2008 Nov;14(6):1004-13. doi: 10.1017/S1355617708081332.

26.

Cross-cultural comparisons of the Mini-mental State Examination between Japanese and U.S. cohorts.

Dodge HH, Meguro K, Ishii H, Yamaguchi S, Saxton JA, Ganguli M.

Int Psychogeriatr. 2009 Feb;21(1):113-22. doi: 10.1017/S1041610208007886. Epub 2008 Oct 17.

27.

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

Raji CA, Becker JT, Tsopelas ND, Price JC, Mathis CA, Saxton JA, Lopresti BJ, Hoge JA, Ziolko SK, DeKosky ST, Klunk WE.

J Neurosci Methods. 2008 Jul 30;172(2):277-82. doi: 10.1016/j.jneumeth.2008.05.005. Epub 2008 May 16.

28.

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.

Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST.

J Neurosci. 2007 Jun 6;27(23):6174-84.

29.

Cognitive domains and trajectories of functional independence in nondemented elderly persons.

Dodge HH, Du Y, Saxton JA, Ganguli M.

J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1330-7.

30.

The relation of white matter hyperintensities to cognitive performance in the normal old: education matters.

Nebes RD, Meltzer CC, Whyte EM, Scanlon JM, Halligan EM, Saxton JA, Houck PR, Boada FE, Dekosky ST.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006 Sep-Dec;13(3-4):326-40.

PMID:
16887777
31.

The association between congestive heart failure and cognitive performance in a primary care population of elderly adults: the Steel Valley Seniors Survey.

Lavery L, Vander Bilt J, Chang CC, Saxton JA, Ganguli M.

Int Psychogeriatr. 2007 Apr;19(2):215-25. Epub 2006 May 10.

PMID:
16684398
32.

Serum anticholinergic activity, white matter hyperintensities, and cognitive performance.

Nebes RD, Pollock BG, Meltzer CC, Saxton JA, Houck PR, Halligan EM, DeKosky ST.

Neurology. 2005 Nov 8;65(9):1487-9.

PMID:
16275844
33.

Alcohol consumption and cognitive function in late life: a longitudinal community study.

Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH.

Neurology. 2005 Oct 25;65(8):1210-7.

PMID:
16247047
34.

Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment.

Rosano C, Aizenstein HJ, Cochran JL, Saxton JA, De Kosky ST, Newman AB, Kuller LH, Lopez OL, Carter CS.

Biol Psychiatry. 2005 Apr 1;57(7):761-7.

35.

Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype.

Perez-Madriñan G, Cook SE, Saxton JA, Miyahara S, Lopez OL, Kaufer DI, Aizenstein HJ, DeKosky ST, Sweet RA.

Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):449-56. Review.

PMID:
15353383
36.

Speed and capacity of language processing test: normative data from an older American community-dwelling sample.

Saxton JA, Ratcliff G, Dodge H, Pandav R, Baddeley A, Ganguli M.

Appl Neuropsychol. 2001;8(4):193-203.

PMID:
11989722
37.

Cognitive correlates of human brain aging: a quantitative magnetic resonance imaging investigation.

Coffey CE, Ratcliff G, Saxton JA, Bryan RN, Fried LP, Lucke JF.

J Neuropsychiatry Clin Neurosci. 2001 Fall;13(4):471-85.

PMID:
11748316
38.

Relation of education to brain size in normal aging: implications for the reserve hypothesis.

Coffey CE, Saxton JA, Ratcliff G, Bryan RN, Lucke JF.

Neurology. 1999 Jul 13;53(1):189-96.

PMID:
10408558
40.

Sex differences in brain aging: a quantitative magnetic resonance imaging study.

Coffey CE, Lucke JF, Saxton JA, Ratcliff G, Unitas LJ, Billig B, Bryan RN.

Arch Neurol. 1998 Feb;55(2):169-79. Review. Erratum in: Arch Neurol 1998 May;55(5):627.

PMID:
9482358
41.

"Brain Drain" Figures.

Saxton JA.

Science. 1964 Mar 27;143(3613):1393. No abstract available.

PMID:
17807838
42.

Effect of long time feeding of whole milk diets to white rats.

SPERLING G, LOVELACE F, BARNES LL, SMITH CA, SAXTON JA Jr, McCAY CM.

J Nutr. 1955 Mar;55(3):399-414. No abstract available.

PMID:
14354474
43.

Pathologic studies of rats fed different amounts of fluids throughout life.

SAXTON JA Jr, SPERLING GA, BARNES LL, McCAY CM.

J Gerontol. 1953 Jul;8(3):255-63. No abstract available.

PMID:
13084897
44.

Weber-Christian disease; a report of two cases treated with cortisone.

HARRISON LB, SAXTON JA Jr.

Mo Med. 1953 Jun;50(6):427-9. No abstract available.

PMID:
13063356
45.

Age changes in relation to the ingestion of milk, water, coffee, and sugar solutions.

McCAY CM, LOVELACE F, SPERLING G, BARNES LL, LIU CH, SMITH CA, SAXTON JA Jr.

J Gerontol. 1952 Apr;7(2):161-72. No abstract available.

PMID:
14927896
46.

Liposarcoma of an extremity associated with multiple subcutaneous lipomas; report of two cases treated by amputation.

STARKLOFF GB, SAXTON JA Jr, JOHNSON RE.

Ann Surg. 1951 Feb;133(2):261-6. No abstract available.

47.

Syphilitic cardiovascular disease combined with chronic endocardial lesions usually attributed to rheumatic fever.

SMITH JR, SAXTON JA Jr, FRITZ HC.

Am J Med. 1951 Jan;10(1):37-46. No abstract available.

PMID:
14799497
48.

Cancer and aging. A survey of the autopsy records of a municipal hospital over a 15 year period.

SAXTON JA Jr, HANDLER FP, BAUER J.

AMA Arch Pathol. 1950 Dec;50(6):813-27. No abstract available.

PMID:
14789325
49.

Hyperplasia of epithelium of renal tubules and glomerular capsules.

HANDLER FP, SAXTON JA Jr.

Am J Clin Pathol. 1950 Dec;20(12):1121-4. No abstract available.

PMID:
14783098
50.

Absorption of 12.5-mm. wave-length electromagnetic radiation in supercooled water.

SAXTON JA, LANE JA.

Nature. 1949 Jun 4;163(4153):871. No abstract available.

PMID:
18130549

Supplemental Content

Loading ...
Support Center